| Net earnings | |
| Impairment charges | 800K |
| Depreciation and amortization | 312.5M |
| Provision for doubtful accounts receivable | 20.4M |
| Share-based compensation | 13.4M |
| Deferred taxes | -33.5M |
| Change in uncertain tax positions | |
| Gain on sale of investments and other assets - net | |
| Loss related to Venezuela currency devaluation | |
| Loss on debt extinguishment | 85.3M |
| Other | 9.6M |
| Accounts receivable-net | -126M |
| Inventories | -57.6M |
| Prepaid expenses and other current assets | -9.2M |
| Accounts payable | -159.6M |
| Income taxes payable and receivable | -35.6M |
| Accrued liabilities and other | |
| Net cash provided by operating activities | |
| Capital expenditures | -147.9M |
| Acquisition of businesses, net of cash acquired | -47.5M |
| Proceeds from return of capital and sale of investments and other assets | |
| Purchases of investments | |
| Transfers from restricted cash | 13.7M |
| Net cash used in investing activities | |
| Proceeds from issuance of long-term debt | 1.16B |
| Net change in short-term debt | 5.7M |
| Payments of current maturities and long-term debt | |
| Net proceeds from credit facility borrowings | |
| Debt issuance costs | -37.5M |
| Issuance of common stock | |
| Payments for the acquisition of common stock | |
| Dividends paid | -163.2M |
| Distributions to noncontrolling interests | |
| Net cash used in financing activities | |
| Effect of exchange rate on cash and cash equivalents | -5.1M |
| Net (decrease) increase in cash and cash equivalents | 22.2M |
| Cash and cash equivalents at beginning of period | 389.6M |
| Cash and cash equivalents at end of period | 411.8M |